Paul Higham

CEO at Pathios Therapeutics Limited

Presenter

Paul is Chief Executive Officer of Pathios and brings extensive leadership experience from both large pharmaceutical and biotech companies. He has over 20 years’ of C-Suite biotech experience covering both public and private companies with the focus for the last 15 years being in the immuno-oncology space. During this time Paul has led three IO-focused companies (Immatics, Glycotope and ValoTx) as CEO, in each creating value by progressing through pre-clinical to the clinic and guiding late-stage clinical development programs. In his earlier career in large pharma, (Bayer and GSK) he gained wide ranging experience in marketing, commercialisation, commercial strategy, business development and finance. He holds an honours degree in Applied Biology.